INTS vs TYL
Intensity Therapeutics, Inc. Common stock (INTS) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported TYL revenue for 2024-12-31 was $2.14B. Net income was $263.0M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
INTS currently screens at market cap $7.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the INTS and TYL stock pages for the full models.
Not investment advice.